Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE Cause Type iv hypersensitivity reaction? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Type iv hypersensitivity reaction have been filed in association with CYTARABINE (cytarabine). This represents 0.0% of all adverse event reports for CYTARABINE.

10
Reports of Type iv hypersensitivity reaction with CYTARABINE
0.0%
of all CYTARABINE reports
0
Deaths
5
Hospitalizations

How Dangerous Is Type iv hypersensitivity reaction From CYTARABINE?

Of the 10 reports, 5 (50.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.

Is Type iv hypersensitivity reaction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE Cause?

Febrile neutropenia (6,142) Off label use (4,183) Pyrexia (2,992) Neutropenia (2,558) Disease progression (2,352) Drug ineffective (2,281) Thrombocytopenia (2,148) Sepsis (2,013) Myelosuppression (1,869) Product use in unapproved indication (1,619)

What Other Drugs Cause Type iv hypersensitivity reaction?

AMOXICILLIN (165) CLINDAMYCIN (128) INFLIXIMAB (120) CEFACLOR (101) IBUPROFEN (98) AMPICILLIN (97) VANCOMYCIN (97) CEPHALEXIN (92) AMOXICILLIN\CLAVULANIC ACID (89) CEFUROXIME (82)

Which CYTARABINE Alternatives Have Lower Type iv hypersensitivity reaction Risk?

CYTARABINE vs CYTARABINE\DAUNORUBICIN CYTARABINE vs DABIGATRAN CYTARABINE vs DABIGATRAN ETEXILATE CYTARABINE vs DABRAFENIB CYTARABINE vs DABRAFENIB\TRAMETINIB

Related Pages

CYTARABINE Full Profile All Type iv hypersensitivity reaction Reports All Drugs Causing Type iv hypersensitivity reaction CYTARABINE Demographics